nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—P2RX4—peripheral nervous system—Parkinson's disease	0.0279	0.0694	CbGeAlD
Suramin—FSHR—hindbrain—Parkinson's disease	0.0262	0.0652	CbGeAlD
Suramin—P2RX4—nerve—Parkinson's disease	0.0217	0.0541	CbGeAlD
Suramin—SIRT1—nerve—Parkinson's disease	0.019	0.0474	CbGeAlD
Suramin—F2—forelimb—Parkinson's disease	0.0184	0.0458	CbGeAlD
Suramin—P2RY2—cardiovascular system—Parkinson's disease	0.013	0.0324	CbGeAlD
Suramin—PLA2G2A—tongue—Parkinson's disease	0.013	0.0324	CbGeAlD
Suramin—SIRT5—forebrain—Parkinson's disease	0.00952	0.0237	CbGeAlD
Suramin—P2RY2—head—Parkinson's disease	0.00883	0.022	CbGeAlD
Suramin—SIRT5—cardiovascular system—Parkinson's disease	0.00805	0.02	CbGeAlD
Suramin—SIRT1—forebrain—Parkinson's disease	0.00789	0.0196	CbGeAlD
Suramin—FSHR—cerebellum—Parkinson's disease	0.0074	0.0184	CbGeAlD
Suramin—SIRT5—medulla oblongata—Parkinson's disease	0.00688	0.0171	CbGeAlD
Suramin—SIRT1—cardiovascular system—Parkinson's disease	0.00667	0.0166	CbGeAlD
Suramin—P2RX4—medulla oblongata—Parkinson's disease	0.00651	0.0162	CbGeAlD
Suramin—RYR1—cardiovascular system—Parkinson's disease	0.00617	0.0153	CbGeAlD
Suramin—P2RX4—spinal cord—Parkinson's disease	0.0058	0.0144	CbGeAlD
Suramin—SIRT1—medulla oblongata—Parkinson's disease	0.0057	0.0142	CbGeAlD
Suramin—SIRT5—head—Parkinson's disease	0.00545	0.0136	CbGeAlD
Suramin—RYR1—medulla oblongata—Parkinson's disease	0.00527	0.0131	CbGeAlD
Suramin—SIRT1—midbrain—Parkinson's disease	0.00521	0.013	CbGeAlD
Suramin—SIRT5—nervous system—Parkinson's disease	0.00517	0.0129	CbGeAlD
Suramin—P2RX4—head—Parkinson's disease	0.00516	0.0128	CbGeAlD
Suramin—SIRT1—spinal cord—Parkinson's disease	0.00508	0.0127	CbGeAlD
Suramin—ARSA—spinal cord—Parkinson's disease	0.00502	0.0125	CbGeAlD
Suramin—SIRT5—central nervous system—Parkinson's disease	0.00498	0.0124	CbGeAlD
Suramin—P2RX4—nervous system—Parkinson's disease	0.00489	0.0122	CbGeAlD
Suramin—SIRT5—cerebellum—Parkinson's disease	0.00487	0.0121	CbGeAlD
Suramin—RYR1—midbrain—Parkinson's disease	0.00481	0.012	CbGeAlD
Suramin—P2RX4—central nervous system—Parkinson's disease	0.00471	0.0117	CbGeAlD
Suramin—PLA2G2A—cardiovascular system—Parkinson's disease	0.00467	0.0116	CbGeAlD
Suramin—P2RX4—cerebellum—Parkinson's disease	0.0046	0.0115	CbGeAlD
Suramin—SIRT1—head—Parkinson's disease	0.00452	0.0112	CbGeAlD
Suramin—ARSA—head—Parkinson's disease	0.00446	0.0111	CbGeAlD
Suramin—SIRT1—nervous system—Parkinson's disease	0.00428	0.0107	CbGeAlD
Suramin—ARSA—nervous system—Parkinson's disease	0.00423	0.0105	CbGeAlD
Suramin—RYR1—head—Parkinson's disease	0.00418	0.0104	CbGeAlD
Suramin—SIRT1—central nervous system—Parkinson's disease	0.00412	0.0103	CbGeAlD
Suramin—ARSA—central nervous system—Parkinson's disease	0.00407	0.0101	CbGeAlD
Suramin—SIRT1—cerebellum—Parkinson's disease	0.00403	0.01	CbGeAlD
Suramin—ARSA—cerebellum—Parkinson's disease	0.00398	0.00991	CbGeAlD
Suramin—RYR1—nervous system—Parkinson's disease	0.00396	0.00985	CbGeAlD
Suramin—SIRT5—brain—Parkinson's disease	0.00395	0.00984	CbGeAlD
Suramin—RYR1—central nervous system—Parkinson's disease	0.00381	0.00948	CbGeAlD
Suramin—P2RX4—brain—Parkinson's disease	0.00374	0.0093	CbGeAlD
Suramin—RYR1—cerebellum—Parkinson's disease	0.00372	0.00927	CbGeAlD
Suramin—PLA2G2A—midbrain—Parkinson's disease	0.00365	0.00908	CbGeAlD
Suramin—F2—cardiovascular system—Parkinson's disease	0.00353	0.00878	CbGeAlD
Suramin—SIRT1—brain—Parkinson's disease	0.00327	0.00815	CbGeAlD
Suramin—PLA2G4A—cardiovascular system—Parkinson's disease	0.00325	0.00809	CbGeAlD
Suramin—ARSA—brain—Parkinson's disease	0.00323	0.00805	CbGeAlD
Suramin—PLA2G2A—head—Parkinson's disease	0.00316	0.00787	CbGeAlD
Suramin—RYR1—brain—Parkinson's disease	0.00303	0.00753	CbGeAlD
Suramin—PLA2G2A—nervous system—Parkinson's disease	0.003	0.00747	CbGeAlD
Suramin—PLA2G2A—central nervous system—Parkinson's disease	0.00289	0.00719	CbGeAlD
Suramin—PLA2G4A—medulla oblongata—Parkinson's disease	0.00278	0.00691	CbGeAlD
Suramin—F2—spinal cord—Parkinson's disease	0.00269	0.00669	CbGeAlD
Suramin—PLA2G4A—midbrain—Parkinson's disease	0.00254	0.00631	CbGeAlD
Suramin—PLA2G4A—spinal cord—Parkinson's disease	0.00248	0.00616	CbGeAlD
Suramin—F2—head—Parkinson's disease	0.00239	0.00594	CbGeAlD
Suramin—PLA2G2A—brain—Parkinson's disease	0.00229	0.00571	CbGeAlD
Suramin—F2—nervous system—Parkinson's disease	0.00226	0.00564	CbGeAlD
Suramin—F2—central nervous system—Parkinson's disease	0.00218	0.00543	CbGeAlD
Suramin—PLA2G4A—nervous system—Parkinson's disease	0.00209	0.00519	CbGeAlD
Suramin—PLA2G4A—central nervous system—Parkinson's disease	0.00201	0.005	CbGeAlD
Suramin—F2—brain—Parkinson's disease	0.00173	0.00431	CbGeAlD
Suramin—PLA2G4A—brain—Parkinson's disease	0.00159	0.00397	CbGeAlD
Suramin—PLA2G2A—Metabolism—GSTA4—Parkinson's disease	0.000255	0.000427	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—DCTN1—Parkinson's disease	0.000255	0.000427	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HTR1A—Parkinson's disease	0.000255	0.000426	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—DRD1—Parkinson's disease	0.000255	0.000426	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000252	0.000421	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TAC1—Parkinson's disease	0.000251	0.00042	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—HTR1A—Parkinson's disease	0.000249	0.000416	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—INS—Parkinson's disease	0.000248	0.000415	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—DRD3—Parkinson's disease	0.000247	0.000413	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—DRD1—Parkinson's disease	0.000246	0.000412	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—TAC1—Parkinson's disease	0.000245	0.00041	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000243	0.000407	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—DRD1—Parkinson's disease	0.00024	0.000402	CbGpPWpGaD
Suramin—ARSA—Metabolism—CYP2E1—Parkinson's disease	0.00024	0.000401	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—GRK5—Parkinson's disease	0.000239	0.0004	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—DRD3—Parkinson's disease	0.000238	0.000399	CbGpPWpGaD
Suramin—ARSA—Metabolism—NQO1—Parkinson's disease	0.000237	0.000397	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—GRM4—Parkinson's disease	0.000236	0.000395	CbGpPWpGaD
Suramin—ARSA—Metabolism—TH—Parkinson's disease	0.000234	0.000391	CbGpPWpGaD
Suramin—F2—Folate Metabolism—IL6—Parkinson's disease	0.000233	0.00039	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—DRD3—Parkinson's disease	0.000233	0.000389	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—ADRBK1—Parkinson's disease	0.000231	0.000385	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PLA2G6—Parkinson's disease	0.00023	0.000384	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—TNF—Parkinson's disease	0.00023	0.000384	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—MCCC1—Parkinson's disease	0.000229	0.000383	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ND3—Parkinson's disease	0.000229	0.000383	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—MAOB—Parkinson's disease	0.000228	0.00038	CbGpPWpGaD
Suramin—F2—Signaling Pathways—VPS35—Parkinson's disease	0.000225	0.000376	CbGpPWpGaD
Suramin—ARSA—Metabolism—CYCS—Parkinson's disease	0.000225	0.000375	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—PENK—Parkinson's disease	0.000224	0.000375	CbGpPWpGaD
Suramin—F2—Hemostasis—FGB—Parkinson's disease	0.000224	0.000374	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—HTR7—Parkinson's disease	0.000223	0.000373	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—DRD2—Parkinson's disease	0.000223	0.000373	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—RPL23A—Parkinson's disease	0.000223	0.000373	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—RPL14—Parkinson's disease	0.000223	0.000373	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—ADRBK1—Parkinson's disease	0.000223	0.000372	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000221	0.00037	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—GRK5—Parkinson's disease	0.000219	0.000366	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000217	0.000362	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—DRD2—Parkinson's disease	0.000216	0.00036	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HTR7—Parkinson's disease	0.000216	0.00036	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—OMD—Parkinson's disease	0.000215	0.00036	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—TALDO1—Parkinson's disease	0.000215	0.00036	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—GRM4—Parkinson's disease	0.000215	0.000359	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—DRD2—Parkinson's disease	0.00021	0.000352	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—HTR7—Parkinson's disease	0.00021	0.000352	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—RPS8—Parkinson's disease	0.000208	0.000348	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—IL6—Parkinson's disease	0.000208	0.000348	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—VPS35—Parkinson's disease	0.000206	0.000344	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—PDYN—Parkinson's disease	0.000205	0.000343	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—FGB—Parkinson's disease	0.000205	0.000342	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—NDUFB11—Parkinson's disease	0.000204	0.000341	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PENK—Parkinson's disease	0.000204	0.00034	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—MAPK8—Parkinson's disease	0.000201	0.000335	CbGpPWpGaD
Suramin—ARSA—Metabolism—COMT—Parkinson's disease	0.000199	0.000332	CbGpPWpGaD
Suramin—ARSA—Metabolism—GSTP1—Parkinson's disease	0.000198	0.000331	CbGpPWpGaD
Suramin—ARSA—Metabolism—MAOA—Parkinson's disease	0.000197	0.00033	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—GRM4—Parkinson's disease	0.000196	0.000328	CbGpPWpGaD
Suramin—ARSA—Metabolism—HMOX1—Parkinson's disease	0.000195	0.000326	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GCH1—Parkinson's disease	0.000195	0.000325	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000194	0.000324	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—GRM5—Parkinson's disease	0.000191	0.000319	CbGpPWpGaD
Suramin—ARSA—Metabolism—ABCB1—Parkinson's disease	0.000187	0.000313	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IGF2—Parkinson's disease	0.000187	0.000313	CbGpPWpGaD
Suramin—F2—Signaling Pathways—DGKQ—Parkinson's disease	0.000187	0.000312	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GPR37—Parkinson's disease	0.000187	0.000312	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PENK—Parkinson's disease	0.000186	0.000311	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PDYN—Parkinson's disease	0.000186	0.000311	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—IL6—Parkinson's disease	0.000185	0.00031	CbGpPWpGaD
Suramin—ARSA—Metabolism—GSTM1—Parkinson's disease	0.000182	0.000304	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IGF1R—Parkinson's disease	0.000181	0.000302	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IGF2—Parkinson's disease	0.000181	0.000302	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—EDN1—Parkinson's disease	0.000179	0.000299	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000176	0.000294	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IGF1R—Parkinson's disease	0.000175	0.000292	CbGpPWpGaD
Suramin—ARSA—Metabolism—GPX1—Parkinson's disease	0.000174	0.000291	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—DBH—Parkinson's disease	0.000174	0.00029	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—FBP1—Parkinson's disease	0.000174	0.00029	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GBA—Parkinson's disease	0.000174	0.00029	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—GRM5—Parkinson's disease	0.000173	0.000289	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—EDN1—Parkinson's disease	0.000173	0.000289	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GPR37—Parkinson's disease	0.000171	0.000285	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—DGKQ—Parkinson's disease	0.000171	0.000285	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000171	0.000285	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PDYN—Parkinson's disease	0.00017	0.000285	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CYP2D6—Parkinson's disease	0.000169	0.000283	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—EDN1—Parkinson's disease	0.000168	0.000282	CbGpPWpGaD
Suramin—F2—Hemostasis—SOD1—Parkinson's disease	0.000166	0.000278	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CTGF—Parkinson's disease	0.000166	0.000278	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—NGF—Parkinson's disease	0.000164	0.000275	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000162	0.000271	CbGpPWpGaD
Suramin—ARSA—Metabolism—MTHFR—Parkinson's disease	0.000161	0.000269	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—NGF—Parkinson's disease	0.000159	0.000265	CbGpPWpGaD
Suramin—F2—Hemostasis—ABL1—Parkinson's disease	0.000158	0.000265	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—GRM5—Parkinson's disease	0.000158	0.000265	CbGpPWpGaD
Suramin—F2—Hemostasis—IGF2—Parkinson's disease	0.000158	0.000264	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—HTR2A—Parkinson's disease	0.000156	0.000261	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000156	0.000261	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000155	0.00026	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CYP2E1—Parkinson's disease	0.000155	0.000259	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—NQO1—Parkinson's disease	0.000153	0.000256	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—SOD1—Parkinson's disease	0.000152	0.000254	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HTR2A—Parkinson's disease	0.000151	0.000252	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—TH—Parkinson's disease	0.000151	0.000252	CbGpPWpGaD
Suramin—ARSA—Metabolism—APOE—Parkinson's disease	0.00015	0.00025	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RIT2—Parkinson's disease	0.000149	0.000249	CbGpPWpGaD
Suramin—F2—Hemostasis—HGF—Parkinson's disease	0.000149	0.000249	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—HTR2A—Parkinson's disease	0.000147	0.000246	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000147	0.000246	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—APOE—Parkinson's disease	0.000145	0.000243	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—ABL1—Parkinson's disease	0.000145	0.000242	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CYCS—Parkinson's disease	0.000145	0.000242	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—IGF2—Parkinson's disease	0.000144	0.000241	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000143	0.000239	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GRK5—Parkinson's disease	0.000141	0.000236	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000141	0.000235	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—APOE—Parkinson's disease	0.00014	0.000235	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—TAC1—Parkinson's disease	0.000138	0.000231	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RIT2—Parkinson's disease	0.000136	0.000228	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—HGF—Parkinson's disease	0.000136	0.000228	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—DRD1—Parkinson's disease	0.000136	0.000227	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000135	0.000225	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—DRD3—Parkinson's disease	0.000132	0.00022	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GRK5—Parkinson's disease	0.000129	0.000216	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—COMT—Parkinson's disease	0.000128	0.000214	CbGpPWpGaD
Suramin—ARSA—Metabolism—INS—Parkinson's disease	0.000128	0.000214	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HTR1A—Parkinson's disease	0.000128	0.000213	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—GSTP1—Parkinson's disease	0.000128	0.000213	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—DDC—Parkinson's disease	0.000127	0.000213	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—MAOA—Parkinson's disease	0.000127	0.000213	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GRM4—Parkinson's disease	0.000127	0.000212	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—HMOX1—Parkinson's disease	0.000126	0.00021	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—TAC1—Parkinson's disease	0.000126	0.00021	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—INS—Parkinson's disease	0.000124	0.000208	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—IGF2—Parkinson's disease	0.000124	0.000207	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—DRD1—Parkinson's disease	0.000123	0.000206	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000123	0.000205	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ABCB1—Parkinson's disease	0.000121	0.000202	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GSTA4—Parkinson's disease	0.00012	0.000201	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PENK—Parkinson's disease	0.00012	0.000201	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MAG—Parkinson's disease	0.00012	0.000201	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—INS—Parkinson's disease	0.00012	0.000201	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—DRD3—Parkinson's disease	0.000119	0.0002	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—HTR7—Parkinson's disease	0.000119	0.000199	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—DRD2—Parkinson's disease	0.000119	0.000199	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000119	0.000199	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—GSTM1—Parkinson's disease	0.000117	0.000196	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HTR1A—Parkinson's disease	0.000117	0.000195	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GRM4—Parkinson's disease	0.000116	0.000194	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—TAC1—Parkinson's disease	0.000115	0.000192	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000113	0.000189	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—DRD1—Parkinson's disease	0.000113	0.000189	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—GPX1—Parkinson's disease	0.000112	0.000188	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000112	0.000186	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PENK—Parkinson's disease	0.00011	0.000184	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PDYN—Parkinson's disease	0.00011	0.000184	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MAG—Parkinson's disease	0.00011	0.000184	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—DRD3—Parkinson's disease	0.000109	0.000183	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PLA2G6—Parkinson's disease	0.000108	0.000181	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—DRD2—Parkinson's disease	0.000108	0.000181	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HTR7—Parkinson's disease	0.000108	0.000181	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—MAOB—Parkinson's disease	0.000107	0.000179	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—MTHFR—Parkinson's disease	0.000104	0.000173	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GFAP—Parkinson's disease	0.000103	0.000173	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GRM5—Parkinson's disease	0.000102	0.000171	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000102	0.000171	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000102	0.000171	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PDYN—Parkinson's disease	0.000101	0.000168	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—DRD2—Parkinson's disease	9.88e-05	0.000165	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HTR7—Parkinson's disease	9.88e-05	0.000165	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—APOE—Parkinson's disease	9.64e-05	0.000161	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—EDN1—Parkinson's disease	9.52e-05	0.000159	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GFAP—Parkinson's disease	9.46e-05	0.000158	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GRM5—Parkinson's disease	9.35e-05	0.000156	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CASP3—Parkinson's disease	9.25e-05	0.000155	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—IL6—Parkinson's disease	9.19e-05	0.000154	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	9.07e-05	0.000152	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FGF20—Parkinson's disease	8.96e-05	0.00015	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CASP3—Parkinson's disease	8.93e-05	0.000149	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—IL6—Parkinson's disease	8.87e-05	0.000148	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ADORA2A—Parkinson's disease	8.69e-05	0.000145	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—EDN1—Parkinson's disease	8.65e-05	0.000145	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MAPK8—Parkinson's disease	8.5e-05	0.000142	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—HTR2A—Parkinson's disease	8.33e-05	0.000139	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—INS—Parkinson's disease	8.24e-05	0.000138	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—INS—Parkinson's disease	8.24e-05	0.000138	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MAPK8—Parkinson's disease	8.21e-05	0.000137	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FGF20—Parkinson's disease	8.2e-05	0.000137	CbGpPWpGaD
Suramin—F2—Signaling Pathways—INSR—Parkinson's disease	8.02e-05	0.000134	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CYP2D6—Parkinson's disease	7.97e-05	0.000133	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ADORA2A—Parkinson's disease	7.95e-05	0.000133	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—EDN1—Parkinson's disease	7.91e-05	0.000132	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CTGF—Parkinson's disease	7.82e-05	0.000131	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FGB—Parkinson's disease	7.58e-05	0.000127	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HTR2A—Parkinson's disease	7.56e-05	0.000126	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HTR1A—Parkinson's disease	7.54e-05	0.000126	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TAC1—Parkinson's disease	7.43e-05	0.000124	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—INSR—Parkinson's disease	7.34e-05	0.000123	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CYP2E1—Parkinson's disease	7.29e-05	0.000122	CbGpPWpGaD
Suramin—F2—Signaling Pathways—DRD1—Parkinson's disease	7.28e-05	0.000122	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—NQO1—Parkinson's disease	7.21e-05	0.00012	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—TH—Parkinson's disease	7.1e-05	0.000119	CbGpPWpGaD
Suramin—F2—Signaling Pathways—DRD3—Parkinson's disease	7.06e-05	0.000118	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FGB—Parkinson's disease	6.93e-05	0.000116	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HTR2A—Parkinson's disease	6.92e-05	0.000116	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HTR1A—Parkinson's disease	6.9e-05	0.000115	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CYCS—Parkinson's disease	6.82e-05	0.000114	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TAC1—Parkinson's disease	6.79e-05	0.000114	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—DRD1—Parkinson's disease	6.66e-05	0.000111	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ADRBK1—Parkinson's disease	6.59e-05	0.00011	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—DRD3—Parkinson's disease	6.45e-05	0.000108	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HTR7—Parkinson's disease	6.38e-05	0.000107	CbGpPWpGaD
Suramin—F2—Signaling Pathways—DRD2—Parkinson's disease	6.38e-05	0.000107	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—COMT—Parkinson's disease	6.04e-05	0.000101	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ADRBK1—Parkinson's disease	6.03e-05	0.000101	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GSTP1—Parkinson's disease	6.01e-05	0.0001	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—MAOA—Parkinson's disease	6e-05	0.0001	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—HMOX1—Parkinson's disease	5.93e-05	9.91e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—DRD2—Parkinson's disease	5.84e-05	9.76e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HTR7—Parkinson's disease	5.84e-05	9.76e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ABCB1—Parkinson's disease	5.69e-05	9.51e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GSTM1—Parkinson's disease	5.52e-05	9.23e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IL6—Parkinson's disease	5.43e-05	9.07e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IGF2—Parkinson's disease	5.35e-05	8.94e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GPX1—Parkinson's disease	5.29e-05	8.84e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IL6—Parkinson's disease	5.24e-05	8.76e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IGF1R—Parkinson's disease	5.17e-05	8.64e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—EDN1—Parkinson's disease	5.11e-05	8.54e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IGF2—Parkinson's disease	4.89e-05	8.18e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—MTHFR—Parkinson's disease	4.88e-05	8.16e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IGF1R—Parkinson's disease	4.73e-05	7.9e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NGF—Parkinson's disease	4.69e-05	7.85e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—EDN1—Parkinson's disease	4.67e-05	7.81e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—APOE—Parkinson's disease	4.54e-05	7.6e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HTR2A—Parkinson's disease	4.47e-05	7.47e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NGF—Parkinson's disease	4.29e-05	7.18e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—APOE—Parkinson's disease	4.15e-05	6.95e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HTR2A—Parkinson's disease	4.09e-05	6.83e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—INS—Parkinson's disease	3.88e-05	6.49e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—APOE—Parkinson's disease	3.8e-05	6.35e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—INS—Parkinson's disease	3.55e-05	5.93e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—INS—Parkinson's disease	3.25e-05	5.43e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CASP3—Parkinson's disease	2.64e-05	4.42e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—IL6—Parkinson's disease	2.63e-05	4.39e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MAPK8—Parkinson's disease	2.43e-05	4.06e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CASP3—Parkinson's disease	2.42e-05	4.04e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—IL6—Parkinson's disease	2.4e-05	4.01e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MAPK8—Parkinson's disease	2.22e-05	3.71e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IL6—Parkinson's disease	1.55e-05	2.59e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IL6—Parkinson's disease	1.42e-05	2.37e-05	CbGpPWpGaD
